VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Trade Payables History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Trade Payables | ₹92 Cr | ₹53 Cr | ₹51 Cr | ₹50 Cr | ₹71 Cr |
What is the latest Trade Payables ratio of VENUS REMEDIES ?
| Year | Trade Payables |
|---|---|
| Mar2025 | ₹92 Cr |
| Mar2024 | ₹53 Cr |
| Mar2023 | ₹51 Cr |
| Mar2022 | ₹50 Cr |
| Mar2021 | ₹71 Cr |
How is Trade Payables of VENUS REMEDIES Trending?
| Years | Trade Payables | % Change | |
|---|---|---|---|
| Mar2025 | ₹92 Cr | 72.72 | |
| Mar2024 | ₹53 Cr | 4.61 | |
| Mar2023 | ₹51 Cr | 1.34 | |
| Mar2022 | ₹50 Cr | -29.70 | |
| Mar2021 | ₹71 Cr | - | |
Compare Trade Payables of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,106.3 Cr | 0.2% | 21.3% | 192.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,647.0 Cr | 0.1% | -0.4% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹157,862.0 Cr | -1.1% | -7.1% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,846.0 Cr | 0.2% | -4.5% | 30.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,720.0 Cr | 0.2% | -4% | 6% | Stock Analytics | |
| CIPLA | ₹98,795.9 Cr | 0% | -9.1% | -18.5% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 0.2% |
21.3% |
192.6% |
| SENSEX | -3.5% |
-12.5% |
-6.5% |
You may also like the below Video Courses